Skip to main content
Premium Trial:

Request an Annual Quote

DynaMetrix, Karolinka Institute Partner with NCI on cSNP Project

NEW YORK, Dec. 8 (GenomeWeb News) - DynaMetrix and the Karolinska Institute announced yesterday that they have partnered with the National Cancer Institute's Cancer Genome Anatomy Project to validate probable causal SNPs that underline differences in protein sequences between individuals.

 

According to DynaMetrix and the Karolinska Institute, these non-synonymous sequence differences - or ns-cSNPs - may be responsible for much of the variation between people in terms of disease risk and drug response.

 

The partners said are using DynaMetrix's DASH-2 genotyping and diagnostic systems to validate the ns-cSNPs in sets of 12, using black and white individuals. Thereafter, DASH will be used to determine allele frequencey distributions in large global populations.

 

Information generated by the project will be made publicly available on a Cancer Genome Anatomy Project website.

 

 

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.